Qiagen Wins FDA Clearance for QIAstat-Dx Syndromic Testing System, Respiratory Panel
Qiagen said today it has launched its QIAstat-Dx syndromic testing system along with the multiplex QIAstat-Dx respiratory panel after receiving FDA 510(k) clearances.
QIAstat-Dx (formerly...
Panel Identifies Hurdles to Wider AI Use in Diagnostic, Rx Development
Artificial intelligence (AI) is gaining a foothold in the discovery and development of drugs and diagnostics—but its use in both will remain limited unless companies surmount hurdles to the technology in the next few years, a panel of industry executives agreed.
BGI Subsidiary Raises Over $200M in Initial Financing Round
MGI, the sequencing instruments subsidiary of BGI Group, said today it has raised more than $200 million in its first financing round—the largest amount...
Study Shows Natera Test Faster than Imaging in Detecting Colorectal Cancer Recurrence
Natera’s Signatera test has shown potential in a newly-published survey for guiding treatment decisions after surgery by identifying colorectal cancer recurrence at an average...
RenalytixAI, UMCG to Partner on Kidney Disease Diagnostic Study
RenalytixAI will assess its lead product, the AI-enabled kidney disease diagnostic KidneyIntelX, in more than 3,500 patients with Type II diabetes through a collaboration...
Former Foundation Medicine Execs Join Hopkins Kimmel Directors, VCs in New Company
Steven Kafka, Ph.D., the former president and chief operating officer of Foundation Medicine who left the company last year, has joined with former colleagues...
Institut Curie, PrediLife Partner on Test for Breast Cancer Risk
PrediLife said it will carry out genetic analyses in connection with its MammoRisk personalized breast cancer screening test through a partnership with the Institut...
MDxHealth Presents Data Supporting Prostate Cancer Tests
MDxHealth has presented positive data designed to demonstrate the accuracy and decision-making value of its two prostate cancer tests, ConfirmMDx and SelectMDx.
The molecular diagnostics...
HTG, Illumina Expand IVD Test Collaboration to Autoimmune, CV, Fibrosis Disorders
HTG Molecular Diagnostics said today it has expanded a 4½-year-old agreement with Illumina allowing for development of in-vitro diagnostic (IVD) test kits for use...
Canopy Biosciences Expands into ‘Multi-Omics’ Company with Zellkraftwerk Acquisition
Canopy Biosciences, a provider of gene editing and gene expression products and services, has acquired Zellkraftwerk for an undisclosed price, in a deal designed...
